Live Breaking News & Updates on Press Release For More Information

Stay updated with breaking news from Press release for more information. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Seasonal Affective Disorder Market to Surpass US$ 794.6 Million by 2027, At a CAGR of 5.5%, Says Coh


Search jobs
05-May-2021
Seasonal Affective Disorder Market to Surpass US$ 794.6 Million by 2027, At a CAGR of 5.5%, Says Coherent Market Insights
SEATTLE, May 05, 2021, (PHARMIWEB)
Global 
Seasonal Affective Disorder Market, by Type (Fall & Winter Seasonal Affective Disorder, Spring & Summer Seasonal Affective Disorder, and Others), by Treatment (Light Therapy, Medications, Psychotherapy, Counselling, and Others), by End User (Hospitals, Clinics, Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 544.7 million in 2020 and is expected to exhibit a CAGR of 5.5% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights. ....

Saudi Arabia , World Health Organization , Al Qahirah , United States , United Kingdom , Eli Lily , Asia Pacific , Bristol Myers Squibb , Koninklijke Philips , Henry Schein Inc , Bayer Ag , Mylan Inc , Institute For Health Metrics , Teva Pharmaceutical Industries Ltd , Pfizer Inc , Abbvie Inc , View Press , Research Institutes , Johnson Services Inc , Bausch Health , Seasonal Affective Disorder Market , Winter Seasonal Affective Disorder , Summer Seasonal Affective Disorder , Light Therapy , End User , North America ,